Intra-Cellular Therapies, Inc. Made Headway

Mon, Jan 13, 2025 at 07:19 PM
Intra-Cellular Therapies, Inc. Made Headway

Intra-Cellular Therapies, Inc. (ITCI:NASDAQ) shot up at $127.19, a gain of 34.1%. On Mon, Jan 13, 2025, ITCI:NASDAQ touched a New 2-Week High of $127.19. The stock got featured on our News Catalysts scanner on Mon, Jan 13, 2025 at 03:42 PM in the 'PATENT' category. From Mon, Dec 30, 2024, the stock recorded 62.50% Up Days and 33.33% Green Days

About Intra-Cellular Therapies, Inc. (ITCI:NASDAQ)

Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.